News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
26 Apr, 2017, 09:00 ET SEOUL, South Korea, April 26, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), the leading developer of multiplex PCR technologies, announced that it is entering into more innovative and powerful business realm by developing the Second-generation Real-time PCR Technology which has been recently patented in the United States and Europe. Seegene’s Second-generation... Read more
FRANKLIN LAKES, N.J., Apr. 26, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to Roche for multiple commercial applications. BD’s patented stochastic labelling technology incorporating molecular indexes (known also as UMIs or molecular barcodes), enables the... Read more
CAMBRIDGE, UK and SAN DIEGO, USA – April 20, 2017 – Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.... Read more
Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more
Hamburg, April 2017 The product line sealed with the new purity grade “Eppendorf Forensic DNA Grade” complies with the stringent requirements of the recently released ISO18385. This standard specifies the demands on manufacturers of products which are used in forensic DNA laboratories to further minimize the risk of contamination. Eppendorf confirms the compliance for every... Read more
Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs CARLSBAD, Calif., April 18, 2017 /PRNewswire/ — Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center... Read more
Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more
Automated Whole-Genome Sequencing Approach Provides Confidence in Results with Increased Sample Throughput and Decreased Turnaround Time Reno, Nev. (April13, 2017) – Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal testing (NIPT). This automated, next-generation sequencing (NGS) workflow is a... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house. The automated comprehensive solution allows laboratories... Read more
News Release April 5, 2017 Your Contact: Karen Tiano +1 978-495-0093 Mobile science lab to visit nine locations through June 2017 Billerica, Massachusetts, April 5, 2017 — MilliporeSigma today announced nine stops for the first half of its national, year-long Curiosity Cube™ tour. Built on the company’s successful Curiosity Labs™ program, the Curiosity Cube™ — a... Read more